M&T Bank Corp Acquires 5,985 Shares of Danaher Corporation $DHR

Key Points

• M&T Bank Corp increased its stake in Danaher by 1.4%, adding 5,985 shares to hold 438,768 shares (about 0.06% of the company) valued at $100.44 million at the end of the quarter.
• Danaher beat quarterly EPS estimates ($2.06 vs. $1.94) while revenue came in slightly below expectations ($5.95B vs. $6.0B), and the company raised its quarterly dividend from $0.32 to $0.40 (annualized $1.60, ~0.9% yield).
• Analysts remain broadly positive—18 Buys and three Holds—with a consensus price target of $240.70, although several firms have recently trimmed their targets.

M&T Bank Corp increased its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 1.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 438,768 shares of the conglomerate's stock after acquiring an additional 5,985 shares during the period. M&T Bank Corp owned about 0.06% of Danaher worth $100,443,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of DHR. JPL Wealth Management LLC bought a new stake in Danaher during the 3rd quarter worth approximately $25,000. WFA of San Diego LLC bought a new stake in Danaher during the 2nd quarter worth approximately $26,000. Elevated Capital Advisors LLC bought a new stake in Danaher during the 4th quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd bought a new stake in Danaher during the 3rd quarter worth approximately $27,000. Finally, Financial Life Planners bought a new position in Danaher in the 3rd quarter valued at $32,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Performance

DHR stock opened at $175.30 on Monday. The business's fifty day moving average is $193.34 and its 200-day moving average is $213.25. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The company has a market cap of $124.07 billion, a P/E ratio of 33.91, a price-to-earnings-growth ratio of 2.34 and a beta of 0.81. Danaher Corporation has a twelve month low of $174.60 and a twelve month high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts' consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm's quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.88 EPS. Equities research analysts forecast that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 24th. Stockholders of record on Friday, March 27th were paid a $0.40 dividend. This is an increase from Danaher's previous quarterly dividend of $0.32. The ex-dividend date of this dividend was Friday, March 27th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher's dividend payout ratio (DPR) is currently 30.95%.

Analyst Upgrades and Downgrades

A number of research analysts have commented on DHR shares. Wolfe Research decreased their price objective on Danaher from $260.00 to $230.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 8th. KeyCorp reiterated an "overweight" rating on shares of Danaher in a research report on Thursday, January 29th. Guggenheim decreased their price objective on Danaher from $275.00 to $235.00 and set a "buy" rating on the stock in a research report on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating on shares of Danaher in a research report on Thursday, January 29th. Finally, Evercore increased their price objective on Danaher from $225.00 to $232.00 and gave the company an "outperform" rating in a research report on Tuesday, April 21st. Eighteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $240.70.

Insider Buying and Selling at Danaher

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the transaction, the executive vice president owned 5,099 shares of the company's stock, valued at $1,060,642.99. This represents a 20.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 10.80% of the stock is currently owned by company insiders.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.